Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Phase II, Multicenter, Open Label Study of YM155 in Subjects with Unresectable Stage III or Metastatic (Stage IV) Melanoma as First-Line Therapy


Collapse Overview 
Collapse sponsor award id
155-CL


Collapse Biography 

Collapse Time 
Collapse start date
2006-03-29

Collapse end date
2007-11-30